ZA764096B - Benzylidene derivatives - Google Patents

Benzylidene derivatives

Info

Publication number
ZA764096B
ZA764096B ZA764096A ZA764096A ZA764096B ZA 764096 B ZA764096 B ZA 764096B ZA 764096 A ZA764096 A ZA 764096A ZA 764096 A ZA764096 A ZA 764096A ZA 764096 B ZA764096 B ZA 764096B
Authority
ZA
South Africa
Prior art keywords
benzylidene derivatives
benzylidene
derivatives
Prior art date
Application number
ZA764096A
Other languages
English (en)
Inventor
M Jalfre
D Giudicelli
J Kaplan
Original Assignee
Synthelabo
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Synthelabo filed Critical Synthelabo
Publication of ZA764096B publication Critical patent/ZA764096B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
    • C07C251/04—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C251/10—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton
    • C07C251/16—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C237/06—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atoms of the carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C249/00—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton
    • C07C249/02—Preparation of compounds containing nitrogen atoms doubly-bound to a carbon skeleton of compounds containing imino groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA764096A 1975-08-01 1976-07-09 Benzylidene derivatives ZA764096B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7524065A FR2319338A1 (fr) 1975-08-01 1975-08-01 Nouveaux derives de a- phenyl benzylideniques des acides amines, leur preparation et les medicaments qui en contiennent

Publications (1)

Publication Number Publication Date
ZA764096B true ZA764096B (en) 1977-06-29

Family

ID=9158650

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA764096A ZA764096B (en) 1975-08-01 1976-07-09 Benzylidene derivatives

Country Status (24)

Country Link
US (2) US4094992A (el)
JP (1) JPS5219644A (el)
AR (1) AR211548A1 (el)
AT (1) AT346312B (el)
AU (1) AU496994B2 (el)
BE (1) BE844737A (el)
CA (1) CA1072112A (el)
CH (1) CH616148A5 (el)
DE (1) DE2634288A1 (el)
DK (1) DK346276A (el)
ES (1) ES450300A1 (el)
FR (1) FR2319338A1 (el)
GB (1) GB1506808A (el)
GR (1) GR60854B (el)
IE (1) IE43143B1 (el)
IL (1) IL50019A (el)
LU (1) LU75514A1 (el)
MX (1) MX4018E (el)
NL (1) NL170627C (el)
NO (1) NO142172C (el)
NZ (1) NZ181444A (el)
PT (1) PT65426B (el)
SE (1) SE429651B (el)
ZA (1) ZA764096B (el)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2516509B1 (fr) * 1981-11-18 1985-07-26 Synthelabo Derives benzylideniques, leur preparation et leur application en therapeutique
FR2484410A2 (fr) * 1979-02-12 1981-12-18 Synthelabo Derives benzylideniques et leur application en therapeutique
DE3124091C2 (de) 1981-06-19 1983-06-01 Degussa Ag, 6000 Frankfurt N-(3-Cyanopropanoyl)-aminocarbonsäureester und deren Verwendung
US4478958A (en) * 1981-07-10 1984-10-23 Kopper Company, Inc. Method for preparing phenolic foams using anhydrous aryl sulfonic acid catalysts
FR2535318B2 (fr) * 1981-11-18 1985-09-06 Synthelabo Derives benzylideniques, leur preparation et leur application en therapeutique
FR2535319B2 (fr) * 1981-11-18 1985-10-31 Synthelabo Derives methyles benzylideniques, leur preparation et leur application en therapeutique
FR2536070A1 (fr) * 1982-11-15 1984-05-18 Synthelabo Diphenyl-azomethines hydroxylees, leur preparation et leur application en therapeutique
FR2536746A1 (fr) * 1982-11-29 1984-06-01 Synthelabo Derives benzylideniques alkyles, leur preparation et leur application en therapeutique
FR2536747A1 (fr) * 1982-11-29 1984-06-01 Synthelabo Derives benzylideniques soufres, leur preparation et leur application en therapeutique
FR2544308B1 (fr) * 1983-04-14 1985-06-14 Synthelabo Ethines substituees, leur preparation et leur application en therapeutique
FR2544309B1 (fr) * 1983-04-14 1986-01-10 Synthelabo Diphenylazomethines hydroxylees, leur preparation et leur application en therapeutique
FR2545822B1 (fr) * 1983-05-11 1985-07-05 Synthelabo Diphenylazomethines portant une chaine esterifiee, leur preparation et leur application en therapeutique
FR2570696B1 (fr) * 1984-09-27 1986-11-21 Synthelabo Derives de diphenylazomethines a chaine insaturee, leur preparation et leur application en therapeutique
FR2577923B1 (fr) * 1985-02-26 1988-09-09 Synthelabo Diphenylazomethines carboxylees, leur preparation et leur application
FR2595695B1 (fr) * 1986-03-12 1988-12-02 Synthelabo Derives de n-(((hydroxy-2 phenyl) (phenyl) methylene) amino-2) ethyl) acetamide, leur preparation et leur application en therapeutique
US5321047A (en) * 1988-06-03 1994-06-14 John Wyeth & Brother, Limited Method and amines used therein
US5278191A (en) * 1988-08-31 1994-01-11 G. D. Searle & Co. Diphenylmethylaminoacetamide derivatives as anti-convulsants
FR2647445B1 (fr) * 1989-05-23 1991-08-30 Oreal Acides n-carboalkyloxy amino-11 undecanoiques et leurs esters, leurs procedes de preparation et leur utilisation en tant qu'agents epaississants
US5247121A (en) * 1989-05-23 1993-09-21 L'oreal Alkyl esters of n-carboalkyloxy amino-11-undecanoic acids, their processes of preparation and their use as thickening agents
US5210313A (en) * 1992-01-10 1993-05-11 Maxdem Incorporated Preparation of 2,5-dichlorobenzophenones
PL365927A1 (en) * 2000-11-30 2005-01-10 Pfizer Products Inc. Combination of gaba agonists and sorbitol dehydrogenase inhibitors
EE200300249A (et) 2000-11-30 2003-10-15 Pfizer Products Inc. GABA agonistide ja aldoosreduktaasi inhibiitoritekombinatsioon
CA2525366A1 (en) * 2003-05-16 2004-11-25 Pfizer Products Inc. Therapeutic combinations of atypical antipsychotics with gaba modulators, anticonvulsants or benzodiazapines
US7109239B2 (en) * 2003-08-20 2006-09-19 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
EP2354120A1 (en) 2003-08-20 2011-08-10 XenoPort, Inc. Synthesis of acyloxyalkyl carbamate prodrugs and intermediates thereof
US20050176680A1 (en) 2003-12-11 2005-08-11 Sepracor, Inc. Combination of sedative and a neurotransmitter modulator, and methods for improving sleep quality and treating depression
EP1737466A1 (en) * 2004-01-29 2007-01-03 Pfizer Products Inc. COMBINATION OF y-AMINOBUTYRIC ACID MODULATORS AND 5-HT-1b RECEPTOR ANTAGONISTS
EP1928437A2 (en) 2005-08-26 2008-06-11 Braincells, Inc. Neurogenesis by muscarinic receptor modulation
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
EP1940389A2 (en) 2005-10-21 2008-07-09 Braincells, Inc. Modulation of neurogenesis by pde inhibition
CA2625210A1 (en) * 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
EP2377531A2 (en) 2006-05-09 2011-10-19 Braincells, Inc. Neurogenesis by modulating angiotensin
CA2651862A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. 5 ht receptor mediated neurogenesis
CN101466390B (zh) * 2006-06-15 2014-03-12 优时比制药有限公司 用于治疗难治性癫痫持续状态的肽类化合物
EP2068872A1 (en) 2006-09-08 2009-06-17 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20090041806A1 (en) * 2007-06-15 2009-02-12 Xenoport, Inc. Use of prodrugs of gaba analogs, antispasticity agents, and prodrugs of gaba b receptor agonists for treating spasticity
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
WO2011113904A1 (en) 2010-03-17 2011-09-22 INSERM (Institut National de la Santé et de la Recherche Médicale) Medicaments for the prevention and treatment of a disease associated with retinal ganglion cell degeneration

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3371085A (en) * 1959-12-10 1968-02-27 Hoffmann La Roche 5-aryl-3h-1,4-benzodiazepin-2(1h)-ones
US3966793A (en) * 1964-06-15 1976-06-29 Clin Midy Intermediates for preparing 1,4-benzodiazepine-2-ones having a carboxylic acid ester or amide group in the 3-position
US3429874A (en) * 1966-12-22 1969-02-25 Schering Corp 1-polyhalogenoalkyl-2-oxo-1,3-dihydro-2h-1,4-benzodiazepines
IL47712A0 (en) 1974-08-21 1975-10-15 Sparamedica Ag Salt of a penicillanic acid derivative,its preparation and pharmaceutical compositions containing it
AT348512B (de) * 1976-08-02 1979-02-26 Hoffmann La Roche Verfahren zur herstellung von isoindol- derivaten

Also Published As

Publication number Publication date
DE2634288C3 (el) 1980-03-13
AR211548A1 (es) 1978-01-30
AU496994B2 (en) 1978-11-16
FR2319338B1 (el) 1982-08-06
CH616148A5 (el) 1980-03-14
CA1072112A (en) 1980-02-19
IE43143L (en) 1977-02-01
JPS5219644A (en) 1977-02-15
ATA556176A (de) 1978-03-15
GR60854B (en) 1978-08-31
NO762658L (el) 1977-02-02
AT346312B (de) 1978-11-10
PT65426A (fr) 1976-08-01
NO142172C (no) 1980-07-09
PT65426B (fr) 1978-02-08
IL50019A0 (en) 1976-09-30
US4400394A (en) 1983-08-23
SE429651B (sv) 1983-09-19
IL50019A (en) 1979-07-25
MX4018E (es) 1981-11-03
DE2634288A1 (de) 1977-02-03
NL7607533A (nl) 1977-02-03
NL170627C (nl) 1982-12-01
JPS5714664B2 (el) 1982-03-25
GB1506808A (en) 1978-04-12
IE43143B1 (en) 1980-12-31
BE844737A (fr) 1977-01-31
US4094992A (en) 1978-06-13
FR2319338A1 (fr) 1977-02-25
NZ181444A (en) 1978-03-06
AU1645076A (en) 1978-02-02
ES450300A1 (es) 1977-09-01
NO142172B (no) 1980-03-31
LU75514A1 (el) 1978-02-09
DE2634288B2 (el) 1979-06-28
DK346276A (da) 1977-02-02
SE7608625L (sv) 1977-02-02

Similar Documents

Publication Publication Date Title
JPS5219644A (en) Benzylidene derivatives
HK23979A (en) Piperidyl-triazine derivatives
GB1550160A (en) 4-hydroxypyrrolidin-2-one derivatives
GB1520812A (en) Benzhydrylsulphinyl derivatives
IL48209A0 (en) Amidinourea derivatives
GB1548621A (en) Nhydrovinca derivatives
AU1597876A (en) Ortho-aminobutyrophenone derivatives
AU1074176A (en) Oxadiazolinone derivatives
IL59758A0 (en) -amino- , -bis-carobxy-alkane derivatives
GB1540845A (en) 6-oxo-pyrimidine derivatives
HK25682A (en) Cis-bicyclooctyl-alkyl-amine derivatives
IE44308L (en) Androsten-17-one derivatives
GB1486104A (en) Phthalimidopiperidine derivatives
GB1554720A (en) Pyridthione derivatives
JPS5248661A (en) 22methoxyybenzamide derivatives
JPS51127100A (en) Triazolobenzocycloalkylthiazine derivatives
GB1545577A (en) N-alkyl-3-phenylisoxazole-4-carboxamide derivatives
JPS5246057A (en) Dicaboxylacte derivatives
GB1551442A (en) 11-methylene-6-piperazinyl-morphanthridine derivatives
GB1520011A (en) Benodioxole derivatives
JPS51127096A (en) Triazorocycloalkylhydrothazine derivatives
GB1520682A (en) Monochloro-striazine derivatives
IL49072A0 (en) Triazolocycloalkylthiadiazine derivatives
GB1484853A (en) Amino-methylhydroxypyranone derivatives
GB1520579A (en) Aminomethylbenzocycloheptene derivatives